129 Xenon Imaging in Patients Treated With Sotatercept

Abroad (travel likely)RecruitingPHASE2

Conditions

Pulmonary Hypertension · Pulmonary Arterial Hypertension

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Duke University Medical Center, Durham, North Carolina, United States
Contact: Study coordinator (Claudia Salazar, BS) · claudia.salazar@duke.edu · 919-660-2026
Contact: Principal Investigator (Sudarshan Rajagopal, MD, PhD)

Study leads

Sudarshan Rajagopal, MD, PhD
Principal Investigator
Duke University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

Pulmonary Arterial Hypertension (PAH) · Pulmonary Hypertension, Interstitial Lung Disease

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Rancho Cordova, United States

Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension

Pulmonary Arterial Hypertension (PAH) · Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) · Pulmonary Hypertension

Abroad (travel likely)Recruiting

São Paulo, Brazil

Sleepiz One+ vs. Capnography and Electrocardiography

Sleep Apnea · Asthma · COPD

Abroad (travel likely)Recruiting

Zurich, Switzerland

DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia

Hereditary Hemorrhagic Telangiectasia · Pulmonary Arterial Hypertension

Abroad (travel likely)RecruitingPHASE1, PHASE2

Camperdown, Australia · Randwick, Australia